Interní Med. 2006; 8(3): 123-127

Severe asthma

MUDr. Milan Teřl Ph.D
Klinika TRN FN a LF UK, Plzeň

The majority of patients with asthma can be relatively easily treated thanks to availability of highly effective medications. In only 5% of asth­matics patients is their disease so severe, that available treatment fails (=severe, therapy-resistant asthma). In the reality, however, more than 50% of astmatic patients remains with poorly controlled disease, 1/3 have severe troubles. In the clinic, it is important to distinguish between real severe and so-called difficult asthma. Asthma may be difficult not only because of the disease factor, but more frequently for doctor or patients factors.

Keywords: Key words: severe asthma, difficult asthma, uncontrolled astma.

Published: June 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Teřl M. Severe asthma. Interní Med. 2006;8(3):123-127.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ayres JG, Miles JF, Barnes PJ. Brittle asthma. Thorax 1998; 53: 315-321. Go to original source... Go to PubMed...
    2. Barnes PJ. Reduced histone deacetylase in COPD: Clinical implications. Chest 2006; 129 (1): 151-155. Go to original source... Go to PubMed...
    3. Busse WW, Holgate ST (eds). Asthma and rhinitis. Cambridge, Massachussetts: Blackwell Science 1995.
    4. Caramori G, Pandit A, Papi A. Is there a difference between chronic airway inflammation in chronic severe asthma and chronic obstructive pulmonary disease? Curr Opin Allergy Clin Immunol 2005; 5 (1): 77-83. Go to original source... Go to PubMed...
    5. Feketeová E, Zelenková J. Non-compliance jako příčina fatálního astmatu. Kazuistiky v pneumologii 2005; 3: 6-8.
    6. Gibson PG, Simpson JL, Saltos N. Heterogenity of airway inflammation in persistent asthma. Chest 2001; 119: 1329-1336. Go to original source... Go to PubMed...
    7. Globální strategie péče o astma a jeho prevenci. Eds. Špičák V, Kašák V, Pohunek P. Praha: ČIPA, Jalna 2003.
    8. Harrison BD. Difficult asthma in adults: recognition and approaches to management. Intern Med J. 2005; 35 (9): 543-547. Go to original source... Go to PubMed...
    9. Heaney LG, Robinson DS. Severe asthma treatment: need for characterising patients. Lancet. 2005; 365 (9463): 974-976. Go to original source... Go to PubMed...
    10. Hunt LW. How to manage diffucult asthma cases. An action plan for physicians and patients. Postgraduate Medicine 2001; 5: 61-69. Go to original source... Go to PubMed...
    11. Chlumsky J. Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent bronchial asthma. Eur Respir J 2001; 18 (Suppl. 33): 335. Go to PubMed...
    12. Chung KF, Godard P (eds). Difficult therapy-resistant asthma. Eur Resp Rev 2000; 10: 101 s.
    13. Kašák V. Asthma bronchiale. Praha: Maxdorf/Jessenius 2005.
    14. Novotná B. Současné výsledky evropského projektu aspirinového astmatu (AIANE). Alergie 2002; 4 (Suppl. 2): 21-23.
    15. Nolte D. Asthma. (5. Ed). München-Wien-Baltimore: Urban &Schwarzenberg 1991.
    16. Sedlák Z, Paráková Z, Král B, et al. Úskalí terapie obtížně léčitelného asthma bronchiale. Stud Pneumol Phtiseol 2004; 4: 164-171. Go to original source...
    17. Špičák V, Vondra V. Asthma bronchiale v dětství a dospělosti. Praha: Avicenum 1988.
    18. Teřl M, Panzner P, Pešek M, Hanzlíková J. Bronchoalveolar lavage in severe persistent asthma. Eur Resp J, 2002; 17 (Suppl. 38): 584.
    19. Teřl M. Chronická obstrukční plicní nemoc. Postgraduální medicína 2001; 3: 259-266.
    20. Wenzel SE. Mechanisms of severe asthma. Clin Exp Allergy 2003; 33: 1622-1628. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.